Standard Biotools (LAB) Gains from Sales and Divestitures (2023 - 2025)
Standard Biotools (LAB) reported Gains from Sales and Divestitures of $8.2 million for Q4 2025, up 2051.96% year-over-year from $383000.0 in Q4 2024, and up 2051.96% quarter-over-quarter from $383000.0 in Q4 2024.
Standard Biotools (LAB) Gains from Sales and Divestitures (2023 - 2025) Analysis & Trends
Standard Biotools (LAB) has 3 years of Gains from Sales and Divestitures data on file, last reported at $8.2 million in Q4 2025.
- Gains from Sales and Divestitures for Q4 2025 came in at $8.2 million, up 2051.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.2 million (up 2051.96% YoY), and the FY2025 annual result was $8.2 million, up 2051.96% from the prior year.
- Gains from Sales and Divestitures improved to $8.2 million in Q4 2025 per LAB's latest filing, from $383000.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $8.2 million in Q4 2025 and troughed at $52000.0 in Q3 2023.
- A 3-year average of $2.1 million and a median of $383000.0 in 2024 frame the typical range for Gains from Sales and Divestitures.
- On a YoY basis, Gains from Sales and Divestitures climbed as much as 7596.15% in 2024 and fell as far as 636.54% in 2024.
- A 3-year view of Gains from Sales and Divestitures shows it stood at $52000.0 in 2023, then jumped by 636.54% to $383000.0 in 2024, then jumped by 2051.96% to $8.2 million in 2025.
- Business Quant data shows LAB's Gains from Sales and Divestitures at $8.2 million in Q4 2025, $383000.0 in Q4 2024, and $4.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Standard Biotools | 319.06 Mn | -136.11 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.24 Mn |
| Dec 31, 2025 | 8.24 Mn |
| Dec 31, 2024 | 383,000.00 |
| Dec 31, 2024 | 383,000.00 |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 283,000.00 |
| Jun 30, 2024 | 283,000.00 |
| Mar 31, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 52,000.00 |
| Dec 31, 2023 | 52,000.00 |
| Sep 30, 2023 | 52,000.00 |
| Sep 30, 2023 | 52,000.00 |